Loading clinical trials...
Loading clinical trials...
This is a prospective, observational, multi-center study with consecutive enrollment. Up to 1,000 patients will be enrolled. The objective of this post-marketing surveillance study is to collect clinical usage patterns of the Benephit Infusion Systems. As a result, FlowMedica will be able to: 1. Better understand and quantify usage patterns including patient characteristics, adjunctive procedures, and infusion agents. 2. Collect user-interface information and overall customer satisfaction. 3. Monitor post-marketing device performance.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Scripps Clinic
La Jolla, California, United States
Owensboro Heart & Vascular
Owensboro, Kentucky, United States
Cardiovascular Institute of the South
Lafayette, Louisiana, United States
Providence Heart & Vascular
Portland, Oregon, United States
Start Date
April 1, 2008
Last Updated
February 5, 2010
1,000
ESTIMATED participants
Targeted Renal Therapy
DEVICE
Lead Sponsor
FlowMedica, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions